| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstracts
|
|
|
1998
|
5 |
1 |
p. 67-75
9 p.
|
artikel
|
| 2 |
Abstracts
|
|
|
1998
|
5 |
1 |
p. 67-75
|
artikel
|
| 3 |
Anticoagulation Management as a Risk Factor for Adverse Events: Grounds for Improvement
|
Jack E. Ansell
|
|
1998
|
5 |
1 |
p. 13-18
6 p.
|
artikel
|
| 4 |
Anticoagulation Management as a Risk Factor for Adverse Events: Grounds for Improvement
|
Ansell, Jack E.
|
|
1998
|
5 |
1 |
p. 13-18
|
artikel
|
| 5 |
Antithrombotic Therapy in Stroke Prevention and Treatment: A Review
|
Marilyn M. Rymer
|
|
1998
|
5 |
1 |
p. 43-47
5 p.
|
artikel
|
| 6 |
Antithrombotic Therapy in Stroke Prevention and Treatment: A Review
|
Rymer, Marilyn M.
|
|
1998
|
5 |
1 |
p. 43-47
|
artikel
|
| 7 |
A Randomized, Blinded Study of Two Doses of Novastan® (Brand of Argatroban) Versus Heparin as Adjunctive Therapy to Recombinant Tissue Plasminogen Activator (Accelerated Administration) in Acute Myocardial Infarction: Rationale and Design of the Myocardial Infarction using Novastan® and T-PA (MINT) Study
|
Ik-Kyung Jang
|
|
1998
|
5 |
1 |
p. 49-52
4 p.
|
artikel
|
| 8 |
A Randomized, Blinded Study of Two Doses of Novastan® (Brand of Argatroban) Versus Heparin as Adjunctive Therapy to Recombinant Tissue Plasminogen Activator (Accelerated Administration) in Acute Myocardial Infarction: Rationale and Design of the Myocardial Infarction using Novastan® and T-PA (MINT) Study
|
Jang, Ik-Kyung
|
|
1998
|
5 |
1 |
p. 49-52
|
artikel
|
| 9 |
Crossreactivity of Human versus Swine Platelet Surface Antigens Is Similar for Glycoproteins Ib and IIIa, but Not for the Glycoprotein IIb/IIIa Complex
|
Victor L. Serebruany
|
|
1998
|
5 |
1 |
p. 37-41
5 p.
|
artikel
|
| 10 |
Crossreactivity of Human versus Swine Platelet Surface Antigens Is Similar for Glycoproteins Ib and IIIa, but Not for the Glycoprotein IIb/IIIa Complex
|
Serebruany, Victor L.
|
|
1998
|
5 |
1 |
p. 37-41
|
artikel
|
| 11 |
Effects of Recombinant Human Megakaryocyte Growth and Development Factor (rHuMGDF) on Platelet Production, Platelet Aggregation, and Thrombosis
|
Fred D. Lott
|
|
1998
|
5 |
1 |
p. 15-23
9 p.
|
artikel
|
| 12 |
Effects of Recombinant Human Megakaryocyte Growth and Development Factor (rHuMGDF) on Platelet Production, Platelet Aggregation, and Thrombosis
|
Lott, Fred D.
|
|
1998
|
5 |
1 |
p. 15-23
|
artikel
|
| 13 |
Evaluation of Hypercoagulable States
|
T.G. DeLoughery
|
|
1998
|
5 |
1 |
p. 43-47
5 p.
|
artikel
|
| 14 |
Evaluation of Hypercoagulable States
|
DeLoughery, T.G.
|
|
1998
|
5 |
1 |
p. 43-47
|
artikel
|
| 15 |
FibrinogenJust a Protein?
|
Hans Martin Hoffmeister
|
|
1998
|
5 |
1 |
p. 61-64
4 p.
|
artikel
|
| 16 |
Fibrinogen–Just a Protein?
|
Hoffmeister, Hans Martin
|
|
1998
|
5 |
1 |
p. 61-64
|
artikel
|
| 17 |
Glucose-Insulin-Potassium Does Not Reduce Myocardial Infarct Size in an Ischemic/Reperfusion Rabbit Model
|
Stephen D. Bellows
|
|
1998
|
5 |
1 |
p. 25-27
3 p.
|
artikel
|
| 18 |
Glucose-Insulin-Potassium Does Not Reduce Myocardial Infarct Size in an Ischemic/Reperfusion Rabbit Model
|
Bellows, Stephen D.
|
|
1998
|
5 |
1 |
p. 25-27
|
artikel
|
| 19 |
Guidelines for the Management of Patients with Acute Myocardial Infarction
|
Richard C. Becker, M.D.
|
|
1998
|
5 |
1 |
p. 73-81
9 p.
|
artikel
|
| 20 |
Guidelines for the Management of Patients with Acute Myocardial Infarction
|
Becker, M.D., Richard C.
|
|
1998
|
5 |
1 |
p. 73-81
|
artikel
|
| 21 |
No Prognostic Importance of Resistance to Activated Protein C in Unstable Coronary Artery Disease Despite Signs of Thrombin Activation
|
Henrik Toss
|
|
1998
|
5 |
1 |
p. 3-7
5 p.
|
artikel
|
| 22 |
No Prognostic Importance of Resistance to Activated Protein C in Unstable Coronary Artery Disease Despite Signs of Thrombin Activation
|
Toss, Henrik
|
|
1998
|
5 |
1 |
p. 3-7
|
artikel
|
| 23 |
Optimal Frequency of Patient Monitoring and Intensity of Oral Anticoagulation Therapy in Valvular Heart Disease
|
Dieter Horstkotte
|
|
1998
|
5 |
1 |
p. 19-24
6 p.
|
artikel
|
| 24 |
Optimal Frequency of Patient Monitoring and Intensity of Oral Anticoagulation Therapy in Valvular Heart Disease
|
Horstkotte, Dieter
|
|
1998
|
5 |
1 |
p. 19-24
|
artikel
|
| 25 |
Outpatient Therapy of Deep Vein Thrombosis
|
Graham F. Pineo
|
|
1998
|
5 |
1 |
p. 29-35
7 p.
|
artikel
|
| 26 |
Outpatient Therapy of Deep Vein Thrombosis
|
Pineo, Graham F.
|
|
1998
|
5 |
1 |
p. 29-35
|
artikel
|
| 27 |
Patient Self-Management of Oral Anticoagulant Therapy: An International Update
|
Alan K. Jacobson
|
|
1998
|
5 |
1 |
p. 25-28
4 p.
|
artikel
|
| 28 |
Patient Self-Management of Oral Anticoagulant Therapy: An International Update
|
Jacobson, Alan K.
|
|
1998
|
5 |
1 |
p. 25-28
|
artikel
|
| 29 |
Platelet Activity in the Early Stage of Acute Myocardial Infarction: Relation to Time of Presentation, Treatment with Either Tissue Plasminogen Activator or Streptokinase and Cyclooxygenase Inhibition
|
Alessandro Salvioni, MD
|
|
1998
|
5 |
1 |
p. 65-71
7 p.
|
artikel
|
| 30 |
Platelet Activity in the Early Stage of Acute Myocardial Infarction: Relation to Time of Presentation, Treatment with Either Tissue Plasminogen Activator or Streptokinase and Cyclooxygenase Inhibition
|
Salvioni, MD, Alessandro
|
|
1998
|
5 |
1 |
p. 65-71
|
artikel
|
| 31 |
Platelet Inhibition in Cardiovascular Disease Management: Aspirin and Beyond
|
Robert A. Harrington
|
|
1998
|
5 |
1 |
p. 37-41
5 p.
|
artikel
|
| 32 |
Platelet Inhibition in Cardiovascular Disease Management: Aspirin and Beyond
|
Harrington, Robert A.
|
|
1998
|
5 |
1 |
p. 37-41
|
artikel
|
| 33 |
Practices in the Prevention of Venous Thromboembolism
|
Frederick A. Anderson, Jr.
|
|
1998
|
5 |
1 |
p. 7-11
5 p.
|
artikel
|
| 34 |
Practices in the Prevention of Venous Thromboembolism
|
Anderson, Frederick A.
|
|
1998
|
5 |
1 |
p. 7-11
|
artikel
|
| 35 |
Preface
|
Jack E. Ansell, M.D.
|
|
1998
|
5 |
1 |
p. 5-5
1 p.
|
artikel
|
| 36 |
Preface
|
Ansell, Jack E.
|
|
1998
|
5 |
1 |
p. 5
|
artikel
|
| 37 |
Prothrombotic Consequences of the Oxidation of Fibrinogen and their Inhibition by Aspirin
|
Gilbert R. Upchurch Jr
|
|
1998
|
5 |
1 |
p. 9-14
6 p.
|
artikel
|
| 38 |
Prothrombotic Consequences of the Oxidation of Fibrinogen and their Inhibition by Aspirin
|
Upchurch, Gilbert R.
|
|
1998
|
5 |
1 |
p. 9-14
|
artikel
|
| 39 |
Survival in Acute Myocardial Infarction Induced by Coronary Ligation: Prognostic Relevanceof Certain Hemostatic Factors During the Occlusion Phase
|
Victor L. Serebruany
|
|
1998
|
5 |
1 |
p. 29-35
7 p.
|
artikel
|
| 40 |
Survival in Acute Myocardial Infarction Induced by Coronary Ligation: Prognostic Relevanceof Certain Hemostatic Factors During the Occlusion Phase
|
Serebruany, Victor L.
|
|
1998
|
5 |
1 |
p. 29-35
|
artikel
|
| 41 |
The Association of Anticoagulant Protein Concentrations with Acute Myocardial Infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Trial
|
Peter W. Callas, Ph.D.
|
|
1998
|
5 |
1 |
p. 53-60
8 p.
|
artikel
|
| 42 |
The Association of Anticoagulant Protein Concentrations with Acute Myocardial Infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Trial
|
Callas, Peter W.
|
|
1998
|
5 |
1 |
p. 53-60
|
artikel
|
| 43 |
The Laboratory of Coagulation A review of present laboratory techniques
|
Fauzia Khan, M.D.
|
|
1998
|
5 |
1 |
p. 83-88
6 p.
|
artikel
|
| 44 |
The Laboratory of Coagulation A review of present laboratory techniques
|
Khan, Fauzia
|
|
1998
|
5 |
1 |
p. 83-88
|
artikel
|
| 45 |
The View from the Inside: Personal Reflections
|
Julie Kurnitz
|
|
1998
|
5 |
1 |
p. 49-51
3 p.
|
artikel
|
| 46 |
The View from the Inside: Personal Reflections
|
Kurnitz, Julie
|
|
1998
|
5 |
1 |
p. 49-51
|
artikel
|
| 47 |
Workshop: Credentialing of Anticoagulation Providers: A Proposed Model
|
Gordon J. Vanscoy
|
|
1998
|
5 |
1 |
p. 53-61
9 p.
|
artikel
|
| 48 |
Workshop: Credentialing of Anticoagulation Providers: A Proposed Model
|
Vanscoy, Gordon J.
|
|
1998
|
5 |
1 |
p. 53-61
|
artikel
|
| 49 |
Workshop: Developing an Agenda for Anticoagulation Management Research
|
Geno J. Merli
|
|
1998
|
5 |
1 |
p. 65-66
2 p.
|
artikel
|
| 50 |
Workshop: Developing an Agenda for Anticoagulation Management Research
|
Merli, Geno J.
|
|
1998
|
5 |
1 |
p. 65-66
|
artikel
|
| 51 |
Workshop: Patient Self-Management: Update of Ongoing Studies in Sweden
|
Lennart Stigendal, and
|
|
1998
|
5 |
1 |
p. 63-64
2 p.
|
artikel
|
| 52 |
Workshop: Patient Self-Management: Update of Ongoing Studies in Sweden
|
Stigendal, Lennart
|
|
1998
|
5 |
1 |
p. 63-64
|
artikel
|
Tijdschrift beschrijving